Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Nov;74(9):1413–1418. doi: 10.1038/bjc.1996.557

NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.

G Lindmark 1
PMCID: PMC2074791  PMID: 8912537

Abstract

This study aimed to investigate whether immunohistochemical staining for nm23-H1 protein in the primary tumour is correlated with tumour stage, tumour differentiation, DNA ploidy, cell proliferative index, p53 status and patient survival time in colorectal cancer. Full-cross colorectal cancer biopsies were collected from 202 consecutive surgical specimens between 1987 and 1990. Immunohistochemical expression of nm23-H1 protein was investigated in cryosections, using a monoclonal anti-nm23-H1 antibody (clone NM 301). The staining pattern was classified as follows: strong homogeneous intensity, moderate homogeneous intensity, moderate focal intensity, or as negative. Immunohistochemical expression of p53 was investigated using a monoclonal anti-p53 antibody (DO-7). The DNA ploidy and cell proliferative index were determined by flow cytometry. Possible correlation between nm23-H1 staining patterns and the other studied tumour characteristics was explored at the end of 1994. Median survival time of living patients was 66 months, range 50-93 months. No correlation was found between various nm23-H1 staining patterns and tumour stage, cell proliferative index or p53 status. Nm23-H1-negative tumours and tumours with moderate focal staining intensity were less differentiated than tumours with strong homogeneous or moderate homogeneous staining intensity (P < 0.05). Of the nm23-H1-negative tumours, a significantly higher number was near-diploid rather than aneuploid, as compared with those expressing positive nm23-H1 (P < 0.05). The number of dead patients in Dukes' stages B and C did not correlate significantly with the nm23-H1 staining pattern. The nm23-H1 staining pattern alone, or combined with either of the other explored tumour characteristics, did not correlate with patient survival time. Immunohistochemical studies of the nm23-H1 protein expression are of minor value in the staging and prognostic prediction of colorectal cancer.

Full text

PDF
1413

Images in this article

1414Figure 1
on p.1414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayhan A., Yasui W., Yokozaki H., Kitadai Y., Tahara E. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63(4):213–218. doi: 10.1007/BF02899264. [DOI] [PubMed] [Google Scholar]
  2. Backer J. M., Mendola C. E., Kovesdi I., Fairhurst J. L., O'Hara B., Eddy R. L., Jr, Shows T. B., Mathew S., Murty V. V., Chaganti R. S. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene. 1993 Feb;8(2):497–502. [PubMed] [Google Scholar]
  3. Bafico A., Varesco L., De Benedetti L., Caligo M. A., Gismondi V., Sciallero S., Aste H., Ferrara G. B., Bevilacqua G. Genomic PCR-SSCP analysis of the metastasis associated NM23-H1 (NME1) gene: a study on colorectal cancer. Anticancer Res. 1993 Nov-Dec;13(6A):2149–2154. [PubMed] [Google Scholar]
  4. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  5. Brewster S. F., Browne S., Brown K. W. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol. 1994 Apr;151(4):1073–1077. doi: 10.1016/s0022-5347(17)35186-8. [DOI] [PubMed] [Google Scholar]
  6. Caligo M. A., Cipollini G., Fiore L., Calvo S., Basolo F., Collecchi P., Ciardiello F., Pepe S., Petrini M., Bevilacqua G. NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer. 1995 Mar 16;60(6):837–842. doi: 10.1002/ijc.2910600619. [DOI] [PubMed] [Google Scholar]
  7. Campo E., Miquel R., Jares P., Bosch F., Juan M., Leone A., Vives J., Cardesa A., Yague J. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer. 1994 Jun 15;73(12):2913–2921. doi: 10.1002/1097-0142(19940615)73:12<2913::aid-cncr2820731207>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  8. Cawkwell L., Lewis F. A., Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer. 1994 Nov;70(5):813–818. doi: 10.1038/bjc.1994.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohn K. H., Wang F. S., Desoto-LaPaix F., Solomon W. B., Patterson L. G., Arnold M. R., Weimar J., Feldman J. G., Levy A. T., Leone A. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet. 1991 Sep 21;338(8769):722–724. doi: 10.1016/0140-6736(91)91444-y. [DOI] [PubMed] [Google Scholar]
  10. DUKES C. E., BUSSEY H. J. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958 Sep;12(3):309–320. doi: 10.1038/bjc.1958.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fearon E. R. Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med. 1994;39:123–147. [PubMed] [Google Scholar]
  12. Flørenes V. A., Aamdal S., Myklebost O., Maelandsmo G. M., Bruland O. S., Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992 Nov 1;52(21):6088–6091. [PubMed] [Google Scholar]
  13. Glimelius B., Isacsson U., Jung B., Påhlman L. Radiotherapy in addition to radical surgery in rectal cancer. Acta Oncol. 1995;34(5):565–570. doi: 10.3109/02841869509094030. [DOI] [PubMed] [Google Scholar]
  14. Haut M., Steeg P. S., Willson J. K., Markowitz S. D. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst. 1991 May 15;83(10):712–716. doi: 10.1093/jnci/83.10.712. [DOI] [PubMed] [Google Scholar]
  15. Heide I., Thiede C., Poppe K., de Kant E., Huhn D., Rochlitz C. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer. Br J Cancer. 1994 Dec;70(6):1267–1271. doi: 10.1038/bjc.1994.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hennessy C., Henry J. A., May F. E., Westley B. R., Angus B., Lennard T. W. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991 Feb 20;83(4):281–285. doi: 10.1093/jnci/83.4.281. [DOI] [PubMed] [Google Scholar]
  17. Hirayama R., Sawai S., Takagi Y., Mishima Y., Kimura N., Shimada N., Esaki Y., Kurashima C., Utsuyama M., Hirokawa K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst. 1991 Sep 4;83(17):1249–1250. doi: 10.1093/jnci/83.17.1249. [DOI] [PubMed] [Google Scholar]
  18. Howlett A. R., Petersen O. W., Steeg P. S., Bissell M. J. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst. 1994 Dec 21;86(24):1838–1844. doi: 10.1093/jnci/86.24.1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Huwer H., Engel M., Welter C., Dooley S., Kalweit G., Feindt P., Gams E. Squamous cell carcinoma of the lung: does the nm23 gene expression correlate to the tumor stage? Thorac Cardiovasc Surg. 1994 Oct;42(5):298–301. doi: 10.1055/s-2007-1016508. [DOI] [PubMed] [Google Scholar]
  20. Iacopetta B., DiGrandi S., Dix B., Haig C., Soong R., House A. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma. Eur J Cancer. 1994;30A(5):664–670. doi: 10.1016/0959-8049(94)90541-x. [DOI] [PubMed] [Google Scholar]
  21. Iizuka N., Oka M., Noma T., Nakazawa A., Hirose K., Suzuki T. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res. 1995 Feb 1;55(3):652–657. [PubMed] [Google Scholar]
  22. Kressner U., Lindmark G., Gerdin B., Påhlman L., Glimelius B. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res. 1996 Mar-Apr;16(2):951–957. [PubMed] [Google Scholar]
  23. Lacombe M. L., Sastre-Garau X., Lascu I., Vonica A., Wallet V., Thiery J. P., Véron M. Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer. 1991;27(10):1302–1307. doi: 10.1016/0277-5379(91)90101-i. [DOI] [PubMed] [Google Scholar]
  24. Leone A., McBride O. W., Weston A., Wang M. G., Anglard P., Cropp C. S., Goepel J. R., Lidereau R., Callahan R., Linehan W. M. Somatic allelic deletion of nm23 in human cancer. Cancer Res. 1991 May 1;51(9):2490–2493. [PubMed] [Google Scholar]
  25. Leone A., Seeger R. C., Hong C. M., Hu Y. Y., Arboleda M. J., Brodeur G. M., Stram D., Slamon D. J., Steeg P. S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 1993 Apr;8(4):855–865. [PubMed] [Google Scholar]
  26. Lindmark G., Gerdin B., Påhlman L., Bergström R., Glimelius B. Prognostic predictors in colorectal cancer. Dis Colon Rectum. 1994 Dec;37(12):1219–1227. doi: 10.1007/BF02257785. [DOI] [PubMed] [Google Scholar]
  27. Lindmark G., Glimelius B., Påhlman L., Enblad P. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis. 1991 May;6(2):115–120. doi: 10.1007/BF00300207. [DOI] [PubMed] [Google Scholar]
  28. Liotta L. A., Stetler-Stevenson W., Steeg P. S. Metastasis suppressor genes. Important Adv Oncol. 1991:85–100. [PubMed] [Google Scholar]
  29. Lombardi D., Sacchi A., D'Agostino G., Tibursi G. The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation. Exp Cell Res. 1995 Apr;217(2):267–271. doi: 10.1006/excr.1995.1086. [DOI] [PubMed] [Google Scholar]
  30. Mandai M., Konishi I., Koshiyama M., Mori T., Arao S., Tashiro H., Okamura H., Nomura H., Hiai H., Fukumoto M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res. 1994 Apr 1;54(7):1825–1830. [PubMed] [Google Scholar]
  31. Myeroff L. L., Markowitz S. D. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst. 1993 Jan 20;85(2):147–152. doi: 10.1093/jnci/85.2.147. [DOI] [PubMed] [Google Scholar]
  32. Nakayama H., Yasui W., Yokozaki H., Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res. 1993 Feb;84(2):184–190. doi: 10.1111/j.1349-7006.1993.tb02853.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Okada K., Urano T., Goi T., Baba H., Yamaguchi A., Furukawa K., Shiku H. Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res. 1994 Aug 1;54(15):3979–3982. [PubMed] [Google Scholar]
  34. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Royds J. A., Cross S. S., Silcocks P. B., Scholefield J. H., Rees R. C., Stephenson T. J. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol. 1994 Mar;172(3):261–266. doi: 10.1002/path.1711720306. [DOI] [PubMed] [Google Scholar]
  36. Royds J. A., Stephenson T. J., Rees R. C., Shorthouse A. J., Silcocks P. B. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst. 1993 May 5;85(9):727–731. doi: 10.1093/jnci/85.9.727. [DOI] [PubMed] [Google Scholar]
  37. Sastre-Garau X., Lacombe M. L., Jouve M., Véron M., Magdelénat H. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer. 1992 Feb 20;50(4):533–538. doi: 10.1002/ijc.2910500406. [DOI] [PubMed] [Google Scholar]
  38. Stahl J. A., Leone A., Rosengard A. M., Porter L., King C. R., Steeg P. S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991 Jan 1;51(1):445–449. [PubMed] [Google Scholar]
  39. Steeg P. S., Bevilacqua G., Kopper L., Thorgeirsson U. P., Talmadge J. E., Liotta L. A., Sobel M. E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 Apr 6;80(3):200–204. doi: 10.1093/jnci/80.3.200. [DOI] [PubMed] [Google Scholar]
  40. Steeg P. S., Cohn K. H., Leone A. Tumor metastasis and nm23: current concepts. Cancer Cells. 1991 Jul;3(7):257–262. [PubMed] [Google Scholar]
  41. Tannapfel A., Köckerling F., Katalinic A., Wittekind C. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum. 1995 Jun;38(6):651–654. doi: 10.1007/BF02054128. [DOI] [PubMed] [Google Scholar]
  42. Tokunaga Y., Urano T., Furukawa K., Kondo H., Kanematsu T., Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer. 1993 Aug 19;55(1):66–71. doi: 10.1002/ijc.2910550113. [DOI] [PubMed] [Google Scholar]
  43. Wang L., Patel U., Ghosh L., Chen H. C., Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res. 1993 Feb 15;53(4):717–720. [PubMed] [Google Scholar]
  44. Whitelaw S. C., Northover J. M. The Nm23 gene and colorectal cancer. Gut. 1994 Jan;35(1):141–141. doi: 10.1136/gut.35.1.141-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Xerri L., Grob J. J., Battyani Z., Gouvernet J., Hassoun J., Bonerandi J. J. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer. 1994 Dec;70(6):1224–1228. doi: 10.1038/bjc.1994.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yamaguchi A., Urano T., Fushida S., Furukawa K., Nishimura G., Yonemura Y., Miyazaki I., Nakagawara G., Shiku H. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer. 1993 Nov;68(5):1020–1024. doi: 10.1038/bjc.1993.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zeng Z. S., Hsu S., Zhang Z. F., Cohen A. M., Enker W. E., Turnbull A. A., Guillem J. G. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer. 1994 Nov;70(5):1025–1030. doi: 10.1038/bjc.1994.442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES